These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 31593523)

  • 21. Conflicts of Interest in Clinical Guidelines: Update of U.S. Preventive Services Task Force Policies and Procedures.
    Ngo-Metzger Q; Moyer V; Grossman D; Ebell M; Woo M; Miller T; Brummer T; Chowdhury J; Kato E; Siu A; Phillips W; Davidson K; Phipps M; Bibbins-Domingo K
    Am J Prev Med; 2018 Jan; 54(1S1):S70-S80. PubMed ID: 29254528
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Implementation of financial disclosure policies to manage conflicts of interest.
    Boyd EA; Lipton S; Bero LA
    Health Aff (Millwood); 2004; 23(2):206-14. PubMed ID: 15046145
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Managing ethical performance in organizations: insights from the corporate world.
    Soule E
    Cleve Clin J Med; 2007 Mar; 74 Suppl 2():S73-6; discussion S77-80. PubMed ID: 17471621
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Conflict of interest and professional medical associations: the North American Spine Society experience.
    Schofferman JA; Eskay-Auerbach ML; Sawyer LS; Herring SA; Arnold PM; Muehlbauer EJ
    Spine J; 2013 Aug; 13(8):974-9. PubMed ID: 23092717
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Conflicts of interest in academic research: policies, processes, and attitudes.
    Lipton S; Boyd EA; Bero LA
    Account Res; 2004; 11(2):83-102. PubMed ID: 15675050
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Industry Support of Patient Advocacy Organizations: The Case for an Extension of the Sunshine Act Provisions of the Affordable Care Act.
    McCoy MS
    Am J Public Health; 2018 Aug; 108(8):1026-1030. PubMed ID: 29927655
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Transparency in relations between multinational R&D pharmaceutical companies' corporate social responsibility activities and patient organizations in the Europe, Japan, and the United States].
    Kato M; Ishikawa H; Okuhara T; Kiuchi T
    Nihon Koshu Eisei Zasshi; 2019; 66(12):746-755. PubMed ID: 31875625
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Creating an institutional conflict-of-interest policy at Johns Hopkins: progress and lessons learned.
    Miller ED
    Cleve Clin J Med; 2007 Mar; 74 Suppl 2():S70-2; discussion S77-80. PubMed ID: 17469476
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Conflict of interest policies and disclosure requirements among European Society of Cardiology National Cardiovascular Journals.
    Alfonso F; Timmis A; Pinto FJ; Ambrosio G; Ector H; Kulakowski P; Vardas P;
    Rev Esp Cardiol (Engl Ed); 2012 May; 65(5):471-8. PubMed ID: 22464101
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Conflicts of interest and conflicts of commitment.
    Werhane P; Doering J
    Prof Ethics; 1995; 4(3-4):47-81. PubMed ID: 11655040
    [No Abstract]   [Full Text] [Related]  

  • 31. Conflict-of-interest policies for investigators in clinical trials.
    Lo B; Wolf LE; Berkeley A
    N Engl J Med; 2000 Nov; 343(22):1616-20. PubMed ID: 11096170
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of conflict of interest policies among organizations producing clinical practice guidelines.
    Brems JH; Davis AE; Clayton EW
    PLoS One; 2021; 16(4):e0249267. PubMed ID: 33930893
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Principles and process in the development of the Mayo Clinic's individual and institutional conflict of interest policy.
    Camilleri M; Gamble GL; Kopecky SL; Wood MB; Hockema ML
    Mayo Clin Proc; 2005 Oct; 80(10):1340-6. PubMed ID: 16212147
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Conflicts of interest and your physician: psychological processes that cause unexpected changes in behavior.
    Sah S
    J Law Med Ethics; 2012; 40(3):482-7. PubMed ID: 23061575
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Professional medical associations and their relationships with industry: a proposal for controlling conflict of interest.
    Rothman DJ; McDonald WJ; Berkowitz CD; Chimonas SC; DeAngelis CD; Hale RW; Nissen SE; Osborn JE; Scully JH; Thomson GE; Wofsy D
    JAMA; 2009 Apr; 301(13):1367-72. PubMed ID: 19336712
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The challenge for NIH ethics policies: preserving public trust and biomedical progress.
    Bravo NR
    Cleve Clin J Med; 2007 Mar; 74 Suppl 2():S29-31; discussion S32-7. PubMed ID: 17469471
    [TBL] [Abstract][Full Text] [Related]  

  • 37. How do health consumer organisations in Australia manage pharmaceutical industry sponsorship? A cross-sectional study.
    Lau E; Fabbri A; Mintzes B
    Aust Health Rev; 2019 Aug; 43(4):474-480. PubMed ID: 30021681
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparison of policy provisions for managing "financial" and "non-financial" interests across health-related research organizations: A qualitative content analysis.
    Grundy Q; Mazzarello S; Bero L
    Account Res; 2020 May; 27(4):212-237. PubMed ID: 32233796
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Coalition Priorité Cancer and the pharmaceutical industry in Quebec: conflicts of interest in the reimbursement of expensive cancer drugs?
    Hughes D; Williams-Jones B
    Healthc Policy; 2013 Aug; 9(1):52-64. PubMed ID: 23968674
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Survey of conflict-of-interest disclosure policies of ophthalmology journals.
    Anraku A; Jin YP; Trope GE; Buys YM
    Ophthalmology; 2009 Jun; 116(6):1093-6. PubMed ID: 19376583
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.